Your browser doesn't support javascript.
loading
The impact of thyroglobulin antibody on efficacy of131I ablation in patients with papillary thyroid carcinoma / 中国癌症杂志
China Oncology ; (12): 476-481, 2017.
Article in Zh | WPRIM | ID: wpr-616288
Responsible library: WPRO
ABSTRACT
Background and purpose:Thyroglobulin antibody (TgAb) is often positive in papillary thyroid carcinoma (PTC) patients. This study aimed to investigate the effect of TgAb on radioiodine ablation efficacy in PTC patients.Methods:A total number of 329 PTC patients with no distant metastasis were included and classified into 2 groups[G1 group (>115 U/mL,n=84) and G2 group (40 U/mL,n=31) and S2 (0.05). TgAb was the only adverse indicator correlating with IBR in multi-logistic regression analysis (P=0.018).Conclusion:TgAb could negatively affect131I ablation efficacy, while increasing the dose of131I failed to improve the success rate in such cases.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: China Oncology Year: 2017 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: China Oncology Year: 2017 Type: Article